Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
13.94
+0.49 (3.64%)
Mar 9, 2026, 4:00 PM EDT - Market closed
TNXP Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 178 | 62 | 24 | 22 | 177 | 129 | |
| Market Cap Growth | 229.91% | 160.94% | 5.35% | -87.36% | 37.35% | 1226.92% | |
| Enterprise Value | -11 | 42 | 18 | -117 | -4 | 75 | |
| Last Close Price | 13.94 | 32.98 | 1289.60 | 7796.00 | 228928.00 | 432000.00 | |
| PS Ratio | 17.32 | 6.11 | 3.04 | - | - | - | |
| PB Ratio | 0.61 | 0.44 | 0.22 | 0.11 | 0.81 | 1.47 | |
| P/TBV Ratio | 0.77 | 0.44 | 0.25 | 0.11 | 0.81 | 1.48 | |
| EV/Sales Ratio | - | 4.17 | 2.30 | - | - | - | |
| Debt / Equity Ratio | 0.00 | 0.06 | 0.09 | 0.00 | 0.00 | 0.02 | |
| Net Debt / Equity Ratio | -0.82 | -0.65 | -0.14 | -0.58 | -0.81 | -0.86 | |
| Net Debt / EBITDA Ratio | 1.95 | 1.22 | 0.13 | 1.08 | 1.93 | 1.50 | |
| Net Debt / FCF Ratio | 2.49 | 1.49 | 0.14 | 0.82 | 1.60 | 1.33 | |
| Asset Turnover | 0.06 | 0.06 | 0.04 | - | - | - | |
| Inventory Turnover | 0.97 | 0.69 | - | - | - | - | |
| Quick Ratio | 9.29 | 5.82 | 1.33 | 6.61 | 8.23 | 7.85 | |
| Current Ratio | 9.89 | 6.50 | 2.53 | 7.19 | 8.71 | 8.96 | |
| Return on Equity (ROE) | -64.99% | -106.12% | -74.61% | -51.76% | -60.25% | -103.98% | |
| Return on Assets (ROA) | -35.94% | -30.62% | -38.93% | -30.03% | -34.03% | -56.00% | |
| Return on Capital Employed (ROCE) | -43.20% | -53.80% | -87.30% | -54.00% | -42.10% | -57.20% | |
| Earnings Yield | -55.63% | -210.97% | -493.86% | -491.58% | -52.02% | -39.07% | |
| FCF Yield | -42.79% | -99.04% | -465.24% | -652.06% | -62.49% | -44.23% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.